BOSCOLO BIELO, LUCA
 Distribuzione geografica
Continente #
AS - Asia 761
EU - Europa 660
NA - Nord America 483
SA - Sud America 99
AF - Africa 32
OC - Oceania 2
Totale 2.037
Nazione #
US - Stati Uniti d'America 467
DE - Germania 300
CN - Cina 271
SG - Singapore 267
IT - Italia 163
BR - Brasile 87
HK - Hong Kong 78
SE - Svezia 47
VN - Vietnam 39
IN - India 34
NL - Olanda 34
RU - Federazione Russa 31
FR - Francia 28
TR - Turchia 23
GB - Regno Unito 17
CI - Costa d'Avorio 16
FI - Finlandia 14
JP - Giappone 10
KR - Corea 10
ID - Indonesia 8
AT - Austria 7
EG - Egitto 7
MX - Messico 7
PL - Polonia 6
AR - Argentina 4
BD - Bangladesh 4
EC - Ecuador 3
ES - Italia 3
ZA - Sudafrica 3
AU - Australia 2
CA - Canada 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
MA - Marocco 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
VE - Venezuela 1
Totale 2.037
Città #
Frankfurt am Main 271
Dallas 141
Ashburn 131
Hefei 91
Singapore 91
Milan 66
Hong Kong 58
Beijing 30
Los Angeles 27
Boardman 23
Bengaluru 20
Istanbul 19
Abidjan 16
Santa Clara 15
Munich 13
Ho Chi Minh City 12
Rome 12
São Paulo 12
Moscow 10
Naples 10
Buffalo 9
New York 9
Seoul 9
Shanghai 9
Tokyo 9
Cangzhou 8
Düsseldorf 8
Hanoi 8
Oklahoma City 7
Atlanta 6
Boston 6
Columbus 6
Council Bluffs 6
Guangzhou 6
Lappeenranta 6
Cairo 5
London 5
Palermo 5
Rho 5
Turku 5
Vienna 5
Chennai 4
Hyderabad 4
Jakarta 4
Paris 4
Seattle 4
Amsterdam 3
Ankara 3
Brescia 3
Brooklyn 3
Chicago 3
Cusano Milanino 3
Helsinki 3
Marseille 3
Mexico City 3
Nuremberg 3
Poplar 3
Quanzhou 3
Rio de Janeiro 3
Roubaix 3
Verona 3
Wroclaw 3
Wuhan 3
Alcamo 2
Anyang 2
Barcelona 2
Baronissi 2
Bauru 2
Berlin 2
Bexley 2
Bron 2
Caivano 2
Can Tho 2
Changchun 2
Cologne 2
Da Nang 2
Dublin 2
Fuzhou 2
Genoa 2
Guayaquil 2
Houston 2
Johannesburg 2
Kingston 2
Lima 2
Lumezzane 2
Manila 2
Mumbai 2
Nantong 2
Padova 2
Salerno 2
San Diego 2
San Francisco 2
San Jose 2
Shenyang 2
Shenzhen 2
Shijiazhuang 2
Sumaré 2
Suzhou 2
Tehran 2
Trieste 2
Totale 1.355
Nome #
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer 194
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents 189
Future potential targets of antibody-drug conjugates in breast cancer 176
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates 146
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact 143
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 122
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments 117
Molecular tumor board in patients with metastatic breast cancer 106
Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study 96
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations 95
Germline BRCA pathogenic variants in patients with ovarian cancer and post-poly (ADP-ribose) polymerase inhibitor myeloid neoplasms 95
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial 89
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit 87
The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis 79
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience 78
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer 65
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis 61
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers 61
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study 50
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology 49
null 3
Totale 2.101
Categoria #
all - tutte 4.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024298 5 5 13 11 18 20 35 23 23 34 54 57
2024/2025625 49 44 50 39 18 10 9 62 51 74 77 142
2025/20261.178 223 252 299 229 108 67 0 0 0 0 0 0
Totale 2.101